Concepedia

David T. Chung

DT

Statistics

Publications

5

Citations

240

H-Index

5

Active since

2009

Affiliations

TaiGen Biotechnology (Taiwan)(Current)

David T. Chung is an author at TaiGen Biotechnology (Taiwan) specializing in medicine, pharmacology, and antimicrobial pharmacology.

Publications per year

2009–2023

5

Publications

5

Improvement of sensory deficits in fragile X mice by increasing cortical interneuron activity after the critical period

Nazim Kourdougli, Anand Suresh, Benjamin Liu et al. · Neuron · 2023 · 69 citations · Full text

, , +17

Efficacy and Safety of Nemonoxacin versus Levofloxacin for Community-Acquired Pneumonia

Dirkie J. Jansen van Rensburg, Reury-Perng Perng, Ismail Mitha et al. · Antimicrobial Agents and Chemotherapy · 2010 · 65 citations · Full text

, , +14

Multiple-Dose Safety, Tolerability, and Pharmacokinetics of Oral Nemonoxacin (TG-873870) in Healthy Volunteers

David T. Chung, Cheng‐Yuan Tsai, Shu‐Jen Chen et al. · Antimicrobial Agents and Chemotherapy · 2009 · 43 citations · Full text

, , +15

Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Nemonoxacin (TG-873870), a Novel Potent Broad-Spectrum Nonfluorinated Quinolone, in Healthy Volunteers

Luke Lin, Li‐Wen Chang, Cheng‐Yuan Tsai et al. · Antimicrobial Agents and Chemotherapy · 2009 · 38 citations · Full text

, , +8

TG-0054, a Novel and Potent Stem Cell Mobilizer, Displays Excellent PK/PD and Safety Profile in Phase I Trial.

David T. Chung, Li‐Wen Chang, Ying‐Huey Huang et al. · Blood · 2009 · 25 citations

, , +11

1–5 of 5